| __timestamp | Intra-Cellular Therapies, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 45967000 |
| Thursday, January 1, 2015 | 87718074 | 114737000 |
| Friday, January 1, 2016 | 93831530 | 183204000 |
| Sunday, January 1, 2017 | 79419009 | 231644000 |
| Monday, January 1, 2018 | 132166913 | 293998000 |
| Tuesday, January 1, 2019 | 89124838 | 357355000 |
| Wednesday, January 1, 2020 | 65782137 | 412084000 |
| Friday, January 1, 2021 | 88845513 | 497153000 |
| Saturday, January 1, 2022 | 134715000 | 705789000 |
| Sunday, January 1, 2023 | 180142000 | 648449000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Ultragenyx Pharmaceutical Inc. have demonstrated a steadfast commitment to advancing medical science. From 2014 to 2023, Ultragenyx's R&D expenses surged by over 1,300%, peaking in 2022, reflecting their aggressive pursuit of groundbreaking therapies. Intra-Cellular Therapies, while more conservative, still increased their R&D spending by approximately 750% during the same period, with a notable spike in 2023. This trend underscores the competitive nature of the biotech industry, where strategic investments in R&D can lead to life-changing innovations. As these companies continue to push the boundaries of science, their financial dedication to R&D serves as a testament to their role as pioneers in the field.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development: Comparing Key Metrics for GSK plc and Ultragenyx Pharmaceutical Inc.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and MannKind Corporation
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Viridian Therapeutics, Inc.